Notice of Lodging of Proposed Consent Decree
Published Date: 7/27/2026
Notice
Summary
No summary available.
No Economic Impacts Identified for this Document
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Related Federal Register Documents
2026-11526, Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018: Dispensing and Administering Controlled Substances for Medication-Assisted Treatment
Starting July 9, 2026, new rules make it easier for doctors and pharmacies to provide medicine that helps people recover from opioid addiction. These changes affect healthcare providers by expanding who can give medication-assisted treatment and how pharmacies can deliver these medicines. The goal? Faster, safer access to treatment with clear rules that save time and support recovery.
2026-10128, Revision of Applications for Manufacturing and Procurement Quotas
The DEA wants to update how companies apply for permission to make and buy certain controlled drugs and chemicals. These changes will make the rules clearer, help prevent drug shortages, and ensure enough supply for medical and scientific needs. If you’re a manufacturer or involved in this process, get ready to follow new steps and share your thoughts by July 20, 2026.
2026-09160, Implementing PATRIOT Act Improvements: Contraband Cigarettes and Smokeless Tobacco
Starting June 8, 2026, new rules crack down harder on illegal cigarette and smokeless tobacco sales. The government lowered the amount that counts as smuggling from 60,000 to just 10,000 cigarettes and now includes smokeless tobacco in the crackdown. Sellers and distributors must keep better records and report more info, making it tougher to dodge the law and protect honest businesses.
2026-14837, Agency Information Collection Activities; Proposed eCollection, eComments Requested; Revision of a Previously Approved Collection; Title-Recordkeeping for the Transfer of Electronic Prescriptions in Schedules III-V between Pharmacies
The DEA is updating rules for pharmacies that transfer electronic prescriptions for certain controlled medicines (Schedules III-V). Pharmacies must keep better records showing where prescriptions go, making it easier to track and safer for everyone. Comments on these changes are open until September 21, 2026, and the update aims to use more electronic tools without adding extra costs.
2026-14935, United States v. Edwards LifeSciences Corp. and Genesis MedTech Group Limited; Proposed Final Judgment and Competitive Impact Statement
The U.S. government says Edwards LifeSciences broke the rules when it bought JC Medical from Genesis MedTech. Edwards must pay $10 million, Genesis pays $2 million, and Edwards has to get approval before buying any company working on special heart valve devices in the U.S. This keeps the market fair and protects competition in heart health tech.
2026-14838, Agency Information Collection Activities; Proposed eCollection, eComments Requested; Revision of a Previously Approved Collection; Title-Recordkeeping for Partial fills of Prescriptions
The DEA is updating how pharmacies and drug handlers keep records when prescriptions are only partly filled. This affects anyone who manages controlled substances and aims to make recordkeeping clearer and easier, with a chance to comment until September 21, 2026. The update won’t cost extra but will help keep drug tracking accurate and smooth.
Previous / Next Documents
Previous: 2026-15065, Certain Adjustable Child Carriers and Components Thereof; Notice of Institution of Investigation
The U.S. International Trade Commission is launching an investigation into certain adjustable child carriers and their parts, following a complaint by Ergo Baby Carrier, Inc. They claim some imported products violate their patents and want the Commission to stop those products from entering or being sold in the U.S. This could lead to new rules that affect sellers and importers soon, possibly blocking some products and impacting sales.
Next: 2026-15067, Agency Information Collection Activities; Comment Request on Employee Plans Compliance Resolution System
In accordance with the Paperwork Reduction Act of 1995, the IRS is inviting comments on the information collection request outlined in this notice.